Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Under his leadership, the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK, Hero ...

Derya Matras will be the new Vice President for Meta in Europe, Middle East and Africa, taking over from Angie Gifford, who announced that she will be leaving her role as VP of EMEA at the end of this ...

Before joining Enormous, Joy Chauhan was Managing Partner (North) and Chief Client Officer at JWT/Wunderman Thompson (now VML) ...

Enormous Brands has appointed Joy Chauhan as Fractional Chief Marketing Officer (CMO). A relatively new approach in the ...

Anti-abortion groups plan to unveil a sprawling federal and state strategy today that would undermine the procedure’s protections enacted by ballot measure in nearly a dozen states over the past two ...

GSK will pay $80 million upfront and as much as $570 million to gain full development and commercialization rights to ...

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

Thousands of apartments have been added — and hundreds taken away — from Greater Philadelphia's pipeline in recent weeks, ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...